OBiO Technology is a gene and cell therapy CRO and CDMO founded. We offer holistic research, development, and manufacturing solutions for vectorology studies, functional genomics, process and analytical development, IND-enabling CMC, clinical and commercial manufacturing. With "enable gene therapy for better lives" as our mission, we are committed to providing high-quality service to global customers, advancing your product from bench to clinic, and bringing benefit to populations around the world. We are committed to provide high quality CDMO service for preclinical, IND, clinical and commercial stages consumers worldwide.

Plasmids, mRNA
AAV, LVV, Ad viral vector,
Cell therapy manufacturing, CAR-T, NK, Treg...
Oncolytic virus 
Technologies
Inducible viral vector packaging
Ultralow endotoxin process
AAVneO for AAV variants with tissue specific tropism

For business inquiries, please contact bd@obiosh.com. More information and job openings at: www.obio-tech.com.



Therapeutics

Manufacturing

Biotechnology

OBiO Tech

Qingmei Xia

Shan Yin

Weiran Shen

Hung Trinh

Swati Dhage

Guodong Javier Jia

Fujie Wang

Qinbin Wu

Bingqing Wang

Guodong Jia

The Leadership Team at OBiO Tech drives strategic direction and operational excellence across the organization. Comprising key executives from research, supply chain, quality assurance, and commercial management, this team collaborates to ensure the successful development and delivery of cutting-edge gene and cell therapy solutions. They are dedicated to fostering innovation, maintaining high-quality standards, and expanding OBiO Tech's impact in the biopharmaceutical industry to ultimately enhance patient lives worldwide.

Leadership Team

Research and Development Team

��

Leadership Team

About

Team members

��������

Leadership Team

About

Team members

��